Structuralformula (Image11)
Rapiblyk Injection, Powder, Lyophilized, For Solution
Product Images NDC 84381-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rapiblyk (NDC 84381-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aop Orphan Pharmaceuticals Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Rapiblyk (Carton)
This text provides detailed information about a pharmaceutical product called Rapiblyk, which is presented in a vial containing 280 mg of landiolol for intravenous infusion after reconstitution. The text includes instructions for dosage, reconstitution, storage, and safety considerations. It also mentions the manufacturer, AOP Orphan Pharmaceuticals GmbH, in Vienna, Austria, and Lyocontract GmbH in Germany. The composition of the product, including excipients like mannitol and sodium hydroxide, is listed. Additionally, it mentions codes such as GTIN, SN, Lot No, EXP Date, and Data Matrix Code that need to be printed or sprayed on the product. This comprehensive information is essential for healthcare professionals and consumers using or prescribing this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
